Insider Trading & Ownership - Connealy Pamela Ann

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Connealy Pamela Ann
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-09-28
Purchase
2023-09-28
4:32 pm
Pyxis Oncology Inc.PYXSConnealy Pamela Ann
CFO and COO
8,000$1.87$14,960818,532
(Direct)
View
2023-09-27
Purchase
2023-09-27
6:36 pm
Pyxis Oncology Inc.PYXSConnealy Pamela Ann
CFO and COO
6,426$1.8468$11,868810,532
(Direct)
View
2023-09-25
Purchase
2023-09-25
5:04 pm
Pyxis Oncology Inc.PYXSConnealy Pamela Ann
CFO and COO
12,000$1.6703$20,044804,106
(Direct)
View
2023-09-22
Purchase
2023-09-22
7:34 pm
Pyxis Oncology Inc.PYXSConnealy Pamela Ann
CFO and COO
5,000$1.739$8,695792,106
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-26
Option Award
2024-03-28
4:33 pm
N/A
N/A
Pyxis Oncology Inc.PYXSConnealy Pamela Ann
CFO & COO
328,710$01,110,293
(Direct)
View
2023-11-29
Tax Withholding
2023-11-30
4:15 pm
N/A
N/A
Pyxis Oncology Inc.PYXSConnealy Pamela Ann
CFO and COO
36,949$1.4781,583
(Direct)
View
2023-09-07
Option Award
2023-09-08
5:02 pm
N/A
N/A
Pyxis Oncology Inc.PYXSConnealy Pamela Ann
CFO and COO
187,793$0782,106
(Direct)
View
2023-07-20
Option Award
2023-07-24
5:11 pm
2024-07-20
2033-07-20
Orchestra BioMed Holdings Inc.OBIOConnealy Pamela Ann
Director
29,167$033,413
(Direct)
View
2023-01-26
Option Award(A)
2023-05-19
5:45 pm
N/A
2032-08-17
Orchestra BioMed Holdings Inc.OBIOConnealy Pamela Ann
Director
23,250$023,250
(Direct)
View
2023-04-12
Exercise
2023-05-05
8:18 pm
N/A
N/A
Orchestra BioMed Holdings Inc.OBIOYanchik Connealy Pamela
Director
758$05,004
(Direct)
View
2023-01-26
Option Award(A)
2023-05-05
8:11 pm
N/A
N/A
Orchestra BioMed Holdings Inc.OBIOYanchik Connealy Pamela
Director
1,516$01,516
(Direct)
View
2023-03-24
Option Award
2023-03-28
4:47 pm
N/A
2031-07-30
Pyxis Oncology Inc.PYXSYanchik Connealy Pamela
CFO and COO
542,372$0926,882
(Direct)
View
2023-03-24
Disposition
2023-03-28
4:47 pm
N/A
2031-07-30
Pyxis Oncology Inc.PYXSYanchik Connealy Pamela
CFO and COO
332,569$0926,882
(Direct)
View
2023-01-26
Option Award
2023-01-30
9:34 pm
N/A
2030-06-29
Orchestra BioMed Holdings Inc.OBIOYanchik Connealy Pamela
Director
45,338$045,338
(Direct)
View

Ownership
2023-01-30
9:19 pm
N/A
2028-01-26
Orchestra BioMed Holdings Inc.OBIOYanchik Connealy Pamela
Director
0$015,000
(Direct)
View
2023-01-03
Option Award
2023-01-03
7:37 pm
N/A
N/A
Pyxis Oncology Inc.PYXSYanchik Connealy Pamela
Chief Financial Officer
43,493$0384,510
(Direct)
View
2022-04-14
Option Award
2022-04-15
8:00 pm
N/A
N/A
Pyxis Oncology Inc.PYXSYanchik Connealy Pamela
Chief Financial Officer
93,493$0341,017
(Direct)
View
2022-03-31
Option Award
2022-04-04
4:15 pm
N/A
N/A
Pyxis Oncology Inc.PYXSYanchik Connealy Pamela
Chief Financial Officer
247,524$0247,524
(Direct)
View
2021-12-06
Option Award
2021-12-07
3:36 pm
N/A
2031-12-06
Pyxis Oncology Inc.PYXSYanchik Connealy Pamela
Chief Financial Officer
52,944$052,944
(Direct)
View

Ownership
2021-10-07
9:07 pm
N/A
2031-07-30
Pyxis Oncology Inc.PYXSYanchik Connealy Pamela
Chief Financial Officer
0$0332,569
(Direct)
View
2021-03-19
Option Award
2021-03-23
08:45 am
N/A
2031-03-19
Immunovant Inc.IMVTYanchik Connealy Pamela
Chief Financial Officer
208,200$0208,200
(Direct)
View
2020-05-15
Option Award
2020-05-18
08:31 am
N/A
2030-05-14
Immunovant Inc.IMVTYanchik Connealy Pamela
Chief Financial Officer
180,500$0180,500
(Direct)
View
2019-12-18
Option Award
2019-12-20
5:02 pm
N/A
2029-11-19
Immunovant Inc.IMVTYanchik Connealy Pamela
Chief Financial Officer
433,588$0433,588
(Direct)
View
(A) Indicate amendment filing.